Literature DB >> 24704293

Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma.

Sheng-Xian Yuan1, Qi-Fei Tao2, Jie Wang3, Fu Yang4, Lei Liu5, Li-Li Wang6, Jin Zhang7, Yuan Yang8, Hui Liu9, Fang Wang10, Shu-Han Sun11, Wei-Ping Zhou12.   

Abstract

About 61-72% of transcribed regions possess long noncoding RNAs in antisense orientation (Antisense long noncoding RNAs, aslncRNAs). However, the function of aslncRNAs in HCC remains unclear. We found numerous aslncRNAs were deregulated and might be involved in regulatory gene-net of HCC. The PCNA-AS1, antisense to PCNA, is significantly up-regulated in HCC and could promote tumor growth in vitro and in vivo. The effects of PCNA-AS1 rely on regulation of PCNA via forming RNA hybridization to increase PCNA mRNA stability. We concluded that aslncRNAs might act as upstream regulators in HCC and PCNA-AS1 could serve as a novel therapeutic target.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antisense RNA; Long noncoding RNA; RNA hybridazation; RNA stability; Tumor growth

Mesh:

Substances:

Year:  2014        PMID: 24704293     DOI: 10.1016/j.canlet.2014.03.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  59 in total

Review 1.  Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.

Authors:  Chun-Ming Wong; Felice Ho-Ching Tsang; Irene Oi-Lin Ng
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-10       Impact factor: 46.802

2.  LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis.

Authors:  Pei Ma; Haitao Wang; Jiangyang Sun; Hongzhou Liu; Chao Zheng; Xin Zhou; Zhongxin Lu
Journal:  Cell Cycle       Date:  2018-06-23       Impact factor: 4.534

3.  Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study.

Authors:  Dina Sabry; Omayma O Abdelaleem; Amani M El Amin Ali; Rehab A Mohammed; Nehal D Abdel-Hameed; Amira Hassouna; Warda A Khalifa
Journal:  Mol Biol Rep       Date:  2019-02-01       Impact factor: 2.316

Review 4.  Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.

Authors:  Mansi A Parasramka; Sayantan Maji; Akiko Matsuda; Irene K Yan; Tushar Patel
Journal:  Pharmacol Ther       Date:  2016-03-22       Impact factor: 12.310

5.  Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.

Authors:  Wen-Ming Chen; Ming-de Huang; Rong Kong; Tong-Peng Xu; Er-Bao Zhang; Rui Xia; Ming Sun; Wei De; Yong-Qian Shu
Journal:  Dig Dis Sci       Date:  2015-02-17       Impact factor: 3.199

6.  Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.

Authors:  Fuqiang Wang; Chengrong Xie; Wenxing Zhao; Zhigang Deng; Huili Yang; Qinliang Fang
Journal:  Clin Exp Med       Date:  2015-10-03       Impact factor: 3.984

Review 7.  ZEB1-AS1: A crucial cancer-related long non-coding RNA.

Authors:  Jinglin Li; Zhenglong Li; Kaiming Leng; Yi Xu; Daolin Ji; Lining Huang; Yunfu Cui; Xingming Jiang
Journal:  Cell Prolif       Date:  2017-12-10       Impact factor: 6.831

8.  TGF-β1 signaling pathway serves a role in HepG2 cell regulation by affecting the protein expression of PCNA, gankyrin, p115, XIAP and survivin.

Authors:  Xin-Hong Wang; Zhi-Guo Chen; Rui-Ling Xu; Cheng-Qian Lv; Jing Liu; Bing Du
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

9.  HBx-related long non-coding RNA MALAT1 promotes cell metastasis via up-regulating LTBP3 in hepatocellular carcinoma.

Authors:  Zhouhua Hou; Xuwen Xu; Xiaoyu Fu; Shuhui Tao; Jiebin Zhou; Shuiping Liu; Deming Tan
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

10.  Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1.

Authors:  Chibo Liu; Jianjun Lin
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.